Geraldine M. Bollard

Higher Infused Lymphocyte Dose Predicts Higher Lymphocyte Recovery, Which in Turn, Predicts Superior Overall Survival following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Devendra Hiwase, Smita Hiwase, Michael Bailey et al. · Biology of Blood and Marrow Transplantation · 2007 · 87 citations · Full text

Cell Therapy, Immunology, Pathology +18

Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma

Devendra Hiwase, Geraldine M. Bollard, Smita Hiwase et al. · Cytotherapy · 2007 · 55 citations

Hematological Malignancy, Intermediate-dose Cy, Cell Therapy +9

Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen

Mark A. Dawson, Anthony P. Schwarer, J. Muirhead et al. · Bone Marrow Transplantation · 2005 · 28 citations

Regenerative Medicine, Translational Medicine, Cell Therapy +15

The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma

Devendra Hiwase, Smita Hiwase, Michael Bailey et al. · Cytotherapy · 2008 · 23 citations

Hematological Malignancy, Oncology, Medicine +11

Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation

Tina Pham, Sushrut Patil, Shaun Fleming et al. · Transfusion · 2015 · 16 citations